Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial
Top Cited Papers
- 31 October 2007
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 8 (10), 881-888
- https://doi.org/10.1016/s1470-2045(07)70278-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgeryEuropean Journal of Surgical Oncology, 2006
- Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC TrialJNCI Journal of the National Cancer Institute, 2006
- International Breast Cancer Study Group Trial of Sentinel Node BiopsyJournal of Clinical Oncology, 2006
- Lymphatic mapping and sentinel lymph node biopsy in early‐stage breast carcinomaCancer, 2005
- Clinicopathologic Factors Associated With False-Negative Sentinel Lymph-Node Biopsy in Breast CancerAnnals of Surgery, 2005
- A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast CancerThe New England Journal of Medicine, 2003
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyThe New England Journal of Medicine, 1998
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- Gamma-probe guided localization of lymph nodesSurgical Oncology, 1993
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992